SHENZHEN, China , Nov. 7, 2024 /PRNewswire/ -- MGI Tech Co., Ltd.
("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced a commercial partnership with Human Cell Atlas (HCA) consortium to further accelerate the human cell mapping initiative. Aimed to facilitate the wider adoption of single cell sequencing and spatial transcriptomics technologies globally, MGI will expand access to its proprietary products within the HCA network by providing discounted rates to collaborating members. "Cutting-edge single cell and spatial genomics are important driving forces for the HCA project," said John Randell, HCA Chief Alliance Officer.
"MGI's involvement in the HCA discount program will enhance the efforts of our collaborative members and help fuel HCA's progress and new scientific discoveries." Under this partnership, HCA members will enjoy more access to MGI's cost-effective and scalable single cell and spatial omics solutions. In addition, MGI will also provide support to members in experimental design, assay execution, and bioinformatic support when applying MGI's technologies to their research.
First introduced in 2019, MGI's single cell series has become one of the company's main product lines. Based on the core DNBSEQä technology, the series addresses the diverse demand of single cell research by offering users a comprehensive and user-friendly solution. The DNBelab C-TaiM 4 portable droplet generator, the lat.